ARS Pharmaceuticals Inc SPRY Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	281.44M	271.19M	258.75M	248.56M	233.19M	227.58M	221.97M	217.6M
Total Current Assets	277.7M	267.35M	255.03M	244.47M	231.73M	226.24M	220.74M	208.79M
Cash and Equivalents	210.52M	87.86M	119.02M	60.53M	70.97M	56.01M	36.63M	39.66M
Total Non-Current Assets	4.06M	4.43M	4.31M	4.71M	2.04M	1.96M	1.86M	9.66M
Total Liabilities	8.55M	10.04M	10.2M	11.27M	2.43M	3.72M	6.73M	16.62M
Total Current Liabilities	5.44M	9.84M	10.05M	11.18M	2.39M	3.72M	6.73M	16.62M
Total Non-Current Liabilities	3.11M	199k	146k	92k	37k	0	0	0
Common Equity	9k	9k	9k	9k	10k	10k	10k	10k
Retained Earnings	-76.94M	-91.9M	-109.27M	-124.14M	-131.3M	-141.6M	-154.11M	-173.24M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	27.55M	15.65M	394.8M	333.47M	281.44M	233.19M
Total Current Assets	20.78M	10.53M	390.66M	261.49M	277.7M	231.73M
Cash and Equivalents	20.16M	9.98M	386.57M	254.05M	210.52M	70.97M
Total Non-Current Assets	-34.98M	-58.78M	382.88M	313.82M	272.89M	230.76M
Total Liabilities	9.35M	21.25M	11.93M	19.65M	8.55M	2.43M
Total Current Liabilities	5.14M	17.93M	9.6M	14.89M	5.44M	2.39M
Total Non-Current Liabilities	4.21M	3.32M	2.33M	4.76M	3.11M	37k
Total Equity	-34.98M	-58.78M	382.88M	313.82M	272.89M	230.76M
Common Equity	0	0	3k	4k	9k	10k
Retained Earnings	-39.82M	-63.79M	-96.73M	-186.21M	-76.94M	-131.3M